Skip to main content

Table 1 Factorial design results

From: Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin

Batch Particle size (mean ± SD, nm) Zeta potential (mean ± SD, mV) Percent drug entrapment (mean ± SD, %)
SLN 1 145 ± 0.57a 20.7 ± 0.22a 62.88 ± 0.99
156 ± 0.64b 15.8 ± 0.13b
SLN 2 168 ± 0.43a 20.2 ± 0.17a 64.21 ± 0.83
179 ± 0.27b 15.4 ± 0.14b
SLN 3 218 ± 0.39a 19.7 ± 0.13a 67.11 ± 0.42
226 ± 0.44b 14.9 ± 0.11b
SLN 4 158 ± 0.55a 17.5 ± 0.22a 82.32 ± 0.89
165 ± 0.56b 13.5 ± 0.19b
SLN 5c 188 ± 0.97a 16.8 ± 0.33a 84.99 ± 0.73
194 ± 0.89b 12.43 ± 0.26b
SLN 6 221 ± 0.6a 16.4 ± 0.11a 85.91 ± 0.64
229 ± 0.41b 12.1 ± 0.17b
SLN 7 164 ± 0.41a 14.3 ± 0.12a 86.58 ± 0.78
172 ± 0.66b 9.6 ± 0.11b
SLN 8 206 ± 0.99a 13.8 ± 0.099a 87.22 ± 0.85
214 ± 0.75b 9.3 ± 0.1b
SLN 9 228 ± 0.54a 13.6 ± 0.092a 89.02 ± 0.66
239 ± 0.48b 8.9 ± 0.098b
  1. aB-SLN
  2. bC-SLN
  3. cOptimized batch